Carlos Fernandez-Larrea

53PUBLICATIONS
263CO-AUTHORS
Medical genetics (excl. cancer genetics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jul 25, 2026
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Jun 12, 2026
Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

|Jun 08, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

|Jun 04, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement.

|May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT.

Pageof 9

Frequent Collaborators

19 joint publications

Aina Oliver-Caldés

18 joint publications

Luis-Gerardo Rodríguez-Lobato

14 joint publications

Laura Rosiñol

11 joint publications

David F Moreno